Working… Menu
Trial record 2 of 2 for:    aminex therapeutics

Study of Orally-Administered AMXT 1501 Dicaprate in Normal Healthy Volunteers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03077477
Recruitment Status : Withdrawn (Change in FDA required patient population decision prior to study start, new protocol developed, this protocol withdrawn)
First Posted : March 13, 2017
Last Update Posted : June 14, 2018
Novella Clinical
Iqvia Pty Ltd
Information provided by (Responsible Party):
Aminex Therapeutics, Inc.

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Actual Primary Completion Date : June 12, 2018
Actual Study Completion Date : June 12, 2018